Internal Medicine, Medical Oncology · Cedar Rapids, IA
NPI
1912053364
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
202 10th Street SE
Cedar Rapids, IA, 52403
Phone (319) 297-2900
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
176,323 services
Medicare patients, 2024
586
Average age 74
Drug cost, 2024
$2.4M
1,084 prescriptions
Company payments, 2025
$1,106
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bharat Jenigiri was code J9271 (injection, pembrolizumab, 1 mg), 26,600 times for 17 patients. In total Bharat Jenigiri billed 176,323 services in 178 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 26,600 | 17 | $44.34 | $1.2M |
| J0185 Injection, aprepitant, 1 mg | Office | 12,350 | 23 | $1.35 | $17K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 8,550 | 12 | $0.11 | $961 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 8,050 | 59 | $0.10 | $781 |
| J0897 Injection, denosumab, 1 mg | Office | 4,080 | 27 | $20.44 | $83K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,005 | 65 | $0.09 | $360 |
| A9575 Injection, gadoterate meglumine, 0.1 ml | Office | 3,300 | 15 | $0.10 | $320 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,300 | 20 | $15.63 | $36K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,231 | 49 | $0.72 | $1,611 |
| 85025 Blood Count | Office | 1,644 | 459 | $7.59 | $12K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,636 | 31 | $0.07 | $120 |
| 80053 Clinical Chemistry | Office | 1,585 | 461 | $10.32 | $16K |
| 36415 Venipuncture Blood Collection | Office | 1,051 | 423 | $8.64 | $9,083 |
| 96375 Injection Administration | Office | 1,044 | 78 | $11.81 | $12K |
| 99214 Office E&M - Established | Office | 875 | 336 | $96.68 | $85K |
By year: 2022 $3.7M for 211,991 services; 2023 $3.2M for 172,686 services; 2024 $3.7M for 176,323 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,644 | 459 | $7.59 | $12K |
| 80053 Clinical Chemistry | 1,585 | 461 | $10.32 | $16K |
| 36415 Venipuncture Blood Collection | 1,051 | 423 | $8.64 | $9,083 |
| 82784 Immunoassay | 379 | 82 | $9.11 | $3,454 |
| 83550 Clinical Chemistry | 338 | 196 | $8.57 | $2,897 |
| 83540 Clinical Chemistry | 338 | 196 | $6.34 | $2,143 |
| 82728 Clinical Chemistry | 335 | 196 | $13.36 | $4,476 |
| 83735 Clinical Chemistry | 221 | 45 | $6.57 | $1,452 |
| 83615 Clinical Chemistry | 180 | 112 | $5.89 | $1,060 |
| 84443 Clinical Chemistry | 168 | 91 | $16.46 | $2,765 |
Medicare prescription drug claims, 2024
In 2024, the drug Bharat Jenigiri prescribed most often to Medicare patients was Anastrozole, with 161 prescriptions and refills. In total Bharat Jenigiri wrote 1,084 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 161 | 239 | 33 | $1,395 |
| Levothyroxine Sodium Generic | 153 | 260 | 27 | $759 |
| Hydroxyurea Generic | 96 | 108 | 12 | $1,602 |
| Prednisone Generic | 44 | 51 | 13 | $213 |
| Eliquis Apixaban | 33 | 41 | Under 11 | $23K |
| Abiraterone Acetate Generic | 31 | 31 | Under 11 | $51K |
| Xarelto Rivaroxaban | 28 | 35 | Under 11 | $21K |
| Venclexta Venetoclax | 25 | 25 | Under 11 | $204K |
| Xtandi Enzalutamide | 21 | 21 | Under 11 | $211K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 21 | 21 | 11 | $195 |
| Erleada Apalutamide | 20 | 20 | Under 11 | $285K |
| Lorazepam Generic | 20 | 20 | Under 11 | $49.62 |
| Lenalidomide Generic | 19 | 19 | Under 11 | $314K |
| Gabapentin Generic | 17 | 19 | Under 11 | $164 |
| Allopurinol Generic | 16 | 22 | Under 11 | $29.95 |
Brand drugs: - claims; generic drugs: 834 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bharat Jenigiri $1,106 ($1,106 in general payments such as food, travel and fees) from 26 companies. The largest payer was Daiichi Sankyo Inc. with $181.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 9 | $181 |
| Janssen Biotech, Inc. JNJ | 9 | $175 |
| Astellas Pharma US Inc 4503.T | 1 | $95.99 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $75.9 |
| Abbvie Inc. ABBV | 3 | $66.42 |
| Merck Sharp & Dohme LLC MRK | 2 | $50 |
| Pfizer Inc. PFE | 5 | $45.32 |
| TerSera Therapeutics LLC | 1 | $38.52 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $32.19 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $32.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.